Technical Analysis for GLAXF - GlaxoSmithKline Plc

Grade Last Price % Change Price Change
grade A 21.19 0.67% 0.1400
GLAXF closed up 0.67 percent on Tuesday, October 22, 2019, on 17 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical GLAXF trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
Bollinger Band Squeeze Range Contraction 0.67%
Narrow Range Bar Range Contraction 0.67%
Gapped Down Weakness 0.67%
Bollinger Band Squeeze Range Contraction 0.33%
Narrow Range Bar Range Contraction 0.33%
Gapped Up Strength 0.33%

Older signals for GLAXF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC; a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma; a strategic collaboration with NeuroMetrix, Inc. to develop and market Quell technology; and strategic alliance with Merck KGaA to jointly develop and commercialize M7824 (bintrafusp alfa), an investigational bifunctional fusion protein immunotherapy. GlaxoSmithKline plc also has a joint research collaboration with Fimbrion Therapeutics Inc. to develop a small molecule candidate for the treatment and prevention of urinary tract infections. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Health Pharmaceutical Industry Pharmaceutical Industry In China Pharmaceutical Products Immunotherapy Hiv Asthma Rare Diseases Urinary Tract Infections Consumer Healthcare Products Decongestants Diclofenac
Is GLAXF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 21.71
52 Week Low 18.14
Average Volume 7,608
200-Day Moving Average 20.0144
50-Day Moving Average 20.6212
20-Day Moving Average 20.9843
10-Day Moving Average 21.0025
Average True Range 0.3481
ADX 29.04
+DI 49.4982
-DI 23.1464
Chandelier Exit (Long, 3 ATRs ) 20.6657
Chandelier Exit (Short, 3 ATRs ) 21.5443
Upper Bollinger Band 21.4511
Lower Bollinger Band 20.5175
Percent B (%b) 0.72
BandWidth 4.44904
MACD Line 0.1202
MACD Signal Line 0.1192
MACD Histogram 0.001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.3400
Resistance 3 (R3) 21.3567 21.3233 21.3150
Resistance 2 (R2) 21.3233 21.2851 21.3150 21.3067
Resistance 1 (R1) 21.2567 21.2615 21.2400 21.2400 21.2983
Pivot Point 21.2233 21.2233 21.2150 21.2150 21.2233
Support 1 (S1) 21.1567 21.1851 21.1400 21.1400 21.0817
Support 2 (S2) 21.1233 21.1615 21.1150 21.0733
Support 3 (S3) 21.0567 21.1233 21.0650
Support 4 (S4) 21.0400